NFKB1 and Barrett esophagus: Finally, curcumin, an active phenol derivative of the spice turmeric, has been hypothesized to have anti-carcinogenic effects and has demonstrated in vitro activity against oncogenic signaling pathways active in BE progression, such as NF-κB; however, no clinical trial of human curcumin supplementation has been conducted at this time [78].